These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 24378008)

  • 21. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients.
    Le Frère-Belda MA; Bats AS; Gillaizeau F; Poulet B; Clough KB; Nos C; Peoc'h M; Seffert P; Bouteille C; Leroux A; Guillemin F; Blanc-Fournier C; Crouet H; Arnould L; Cuisenier J; Penault-Llorca F; Gimbergues P; Jacquemier J; Houvenaeghel G; Chatellier G; Lécuru F
    Int J Cancer; 2012 May; 130(10):2377-86. PubMed ID: 21780107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumoral load quantification of positive sentinel lymph nodes in breast cancer to predict more than two involved nodes.
    Piñero-Madrona A; Ruiz-Merino G; Bernet L; Miguel-Martínez B; Vicente-García F; Viguri-Díaz MA; Giménez-Climent J
    Breast; 2014 Dec; 23(6):859-64. PubMed ID: 25283682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of molecular intra-operative assessment of sentinel lymph node in breast cancer.
    Khaddage A; Berremila SA; Forest F; Clemenson A; Bouteille C; Seffert P; Peoc'h M
    Anticancer Res; 2011 Feb; 31(2):585-90. PubMed ID: 21378342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple Step-section Frozen Section sentinel lymph node biopsy--a review of 717 patients.
    Lim J; Govindarajulu S; Sahu A; Ibrahim N; Magdub S; Cawthorn S
    Breast; 2013 Oct; 22(5):639-42. PubMed ID: 23953247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
    Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
    J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Achieving breast cancer surgery in a single setting with intraoperative frozen section analysis of the sentinel lymph node.
    Lu Q; Tan EY; Ho B; Teo C; Seah MD; Chen JJ; Chan PM
    Clin Breast Cancer; 2013 Apr; 13(2):140-5. PubMed ID: 23218472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).
    Godey F; Leveque J; Tas P; Gandon G; Poree P; Mesbah H; Lavoue V; Quillien V; Athias CB
    Breast Cancer Res Treat; 2012 Jan; 131(2):509-16. PubMed ID: 21993859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
    Shimazu K; Sato N; Ogiya A; Sota Y; Yotsumoto D; Ishikawa T; Nakamura S; Kinoshita T; Tsuda H; Ohi Y; Akiyama F; Noguchi S
    Ann Surg Oncol; 2018 Sep; 25(9):2603-2611. PubMed ID: 29978372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of onestep nucleic acid amplification (OSNA) and tumour related factors in the treatment of axillary breast cancer: A predictive model.
    Banerjee SM; Williams NR; Davidson TI; El Sheikh S; Tran-Dang M; Davison S; Ghosh D; Keshtgar MR
    Eur J Surg Oncol; 2016 May; 42(5):641-9. PubMed ID: 26979647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE; Gatmaitan P; Garguilo G
    Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Takamoto K; Shimazu K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Tamaki Y; Noguchi S
    Ann Surg Oncol; 2016 Jan; 23(1):78-86. PubMed ID: 26152274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of CK-IHC assay on serial frozen sections, the OSNA assay, and in combination for intraoperative evaluation of SLN metastases in breast cancer.
    Shigematsu H; Ozaki S; Yasui D; Zaitsu J; Taniyama D; Saitou A; Kuraoka K; Yamashiro H; Taniyama K
    Breast Cancer; 2018 Mar; 25(2):191-197. PubMed ID: 29094254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of sentinel lymph node metastases in cervical cancer: assessment of KRT19 mRNA in the one-step nucleic acid amplification (OSNA) method.
    Okamoto S; Niikura H; Nakabayashi K; Hiyama K; Matoda M; Takeshima N; Watanabe M; Nagase S; Otsuki T; Yaegashi N
    Gynecol Oncol; 2013 Sep; 130(3):530-6. PubMed ID: 23811115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.